References
- Mathews M B, Bernstein R M, Franza B R, Garrels J I. Identity of the proliferating cell nuclear antigen and cyclin. Nature 1984; 303: 374–6
- Kurki P, Ogata K, Tan E M. Monoclonal antibodies to proliferating cell nuclear antigen (PCNA)/cyclin as probes for proliferating cells by immunofluorescence microscopy and flow cytometry. J Immunol Meth 1988; 109: 49–59
- Waseem N H, Lane D P. Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA): structural conservation and the detection of a nuclear form. J Cell Sci 1990; 96: 121–9
- Woods A L, Hall P A, Shepherd N A, Hanby A M, Waseem N H, Lane D P. The assessment of proliferating cell nuclear antigen (PCNA) immunostaining in primary gastrointestinal lymphomas and its relationship to histological grade S + G2 + M phase fraction (flow cytometric analysis) and prognosis. Histopathology 1991; 19: 21–7
- Theunissen PHMH, Leers MPG, Bollen ECM. Proliferating cell nuclear antigen (PCNA) expression in formalin-fixed tissue of non-small lung carcinoma. Histopathology 1992; 20: 251–5
- Nemoto R, Kawamura H, Miyakawa I, Uchida K, Hattori K, Koiso K. Immunohistochemical detection of proliferating cell nuclear antigen (PCNA)/cyclin in human prostate adenocarcinoma. J Urol 1993; 149: 165–9
- Roa I, Araya J, Shiraishi T, Yatani R, Villaseca M, Wistuba I. Proliferating cell nuclear antigen in gallbladder carcinoma. Histopathology 1993; 23: 179–83
- Japanese Society of Biliary Surgery. General rules for surgical and pathological studies on cancer of biliary tract. 3rd ed. Kanehara, Tokyo 1993
- Morris G F, Mathews M B. Regulation of proliferating cell nuclear antigen during the cell cycle. J Biol Chem 1989; 264: 13856–64
- Kamel O W, LeBrun D P, Davis R E, Berry G J, Warnke R A. Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti PCNA/cyclin 19A2. Am J Pathol 1991; 138: 1471–7
- Celis J E, Celis A. Cell cycle-dependent variations in the distribution of the nuclear protein cyclin proliferating cell nuclear antigen in cultured cells: subdivision of S phase. Proc Natl Acad Sci (USA) 1985; 82: 3262–6
- Coltrera M D, Gown A M. PCNA/cyclin expression and BrdU uptake define different subpopulations in different cell lines. J Histochem Cytochem 1991; 39: 23–30
- Garcia R L, Coltrera M D, Gown A M. Analysis of proliferative grade using anti PCNA/cyclin monoclonal antibodies in fixed embedded tissues. Am J Pathol 1989; 134: 733–9
- Kitamoto M, Nakanishi T, Kira S, Kawaguchi M, Nakashio R, Suemori S. The assessment of proliferating cell nuclear antigen immunohistochemical staining in small hepatocellular carcinoma and its relationship to histologic characteristics and prognosis. Cancer 1993; 72: 1859–65
- Montironi R, Galluzzi C M, Diamanti L, Giannulis I, Scarpelli M, Nictolis M D. Proliferating cell nuclear antigen (PCNA) in prostatic invasive adenocarcinoma. Is the proliferation state in the marginal zone of the tumour higher than in the central part. Anticancer Res 1993; 13: 129–32
- Yu CCW, Hall P A, Fletcher CDM, Camplejohns R S, Waseem N H, Lane D P. Haemangio-pericytomas: the prognostic value of immunohistochemical staining with a monoclonal antibody to proliferating cell nuclear antigen (PCNA). Histopathology 1991; 19: 29–33
- Jain S, Fillipe M I, Hall P A, Waseem N, Lane D P, Levinson D A. Prognostic value of proliferating cell nuclear antigen in gastric carcinoma. J Clin Pathol 1991; 44: 655–59
- Ng IOL, Lai ECS, Fan S T, Ng M, Chan ASY, So MKP. Prognostic significance of proliferating cell nuclear antigen expression in hepatocellular carcinoma. Cancer 1994; 73: 2268–74
- Gillett C E, Barnes D M, Camplejohn R S. Comparison of three cell cycle associated antigens as markers of proliferative activity and prognosis in breast carcinoma. J Clin Pathol 1993; 46: 1126–8
- Gasparini G, Meli S, Pozza F, Cazzavillan S, Bevilacqua P. PC-10 antibody to proliferating cell nuclear antigen (PCNA) is not related to prognosis in human breast carcinoma. Growth Regul 1992; 2: 145–50